A Comparison of Three Methods for the Determination of the Growth Fraction in Non-Hodgkin's Lymphoma

Overview

Journal Br J Cancer

Specialty Oncology

Date 1987 Mar 1

PMID 3567062

Citations 17

Authors

S Schrape

D B Jones

D H Wright

Affiliations

Soon will be listed here.

Abstract

The proliferation rate of non-Hodgkin's lymphomas (NHL) was estimated by using 3 different methods. In cell suspension we determined the proportion of cells in cycle with the monoclonal antibody (Mab) Ki-67 and also in S-phase after the incorporation of bromo-deoxyuridine (BrdU) utilizing Mab anti-BrdU. In low grade lymphomas 3.5 +/- 1.6% of the cells were in cycle and 1.2 +/- 0.9% in S-phase, the corresponding values for high grade lymphomas were 22.5 +/- 18.7% and 8.9 +/- 7.8% respectively. Frozen sections of NHL were reacted with an antibody to the transferrin receptor (TR) and Ki67 as markers for proliferative activity. A high number of TR positive cells was found in low grade lymphomas of all histological types, whereas Ki67 positivity correlated closely with grading. With a few exceptions, low grade lymphomas contained less than 25% Ki67 positive cells within the tumour cell population. This observation is relevant to treatment strategies for low grade NHL.

Citing Articles

Proliferation markers in tumours: interpretation and clinical value.

van Diest P, Brugal G, Baak J J Clin Pathol. 1999; 51(10):716-24.

PMID: 10023332 PMC: 500923. DOI: 10.1136/jcp.51.10.716.

Comparison of immunostainings for proliferating cell nuclear antigen and Ki-67 in human extraocular lesions.

Kodama T, Kawamoto K, Kono T, Shibuya Y, SETOGAWA T Graefes Arch Clin Exp Ophthalmol. 1998; 235(12):767-72.

PMID: 9439969 DOI: 10.1007/BF02332861.

The correlation of Ki-67 staining indices with tumour doubling times in regrowing non-functioning pituitary adenomas.

Ekramullah S, Saitoh Y, Arita N, Ohnishi T, Hayakawa T Acta Neurochir (Wien). 1996; 138(12):1449-55.

PMID: 9030353 DOI: 10.1007/BF01411125.

The significance of Ki-67, BrdU and OKT9 expression in determination of myelodysplastic syndromes by use of APAAP technique.

Yi F, Wang B, Liu X J Tongji Med Univ. 1993; 13(1):30-3.

PMID: 8326526 DOI: 10.1007/BF02886590.

The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins.

Schluter C, Duchrow M, Wohlenberg C, BECKER M, Key G, Flad H J Cell Biol. 1993; 123(3):513-22.

PMID: 8227122 PMC: 2200129. DOI: 10.1083/jcb.123.3.513.

References

Costa A, Bonadonna G, Villa E, Valagussa P, Silvestrini R . Labeling index as a prognostic marker in non-Hodgkin's lymphomas. J Natl Cancer Inst. 1981; 66(1):1-5. View

Jones D, Wright D, Paul F, Smith J . Phenotypic heterogeneity displayed by T-non Hodgkin's lymphoma (T-NHL) cells dispersed from diagnostic lymph node biopsies. Hematol Oncol. 1986; 4(3):219-26. DOI: 10.1002/hon.2900040306. View

Trowbridge I, Omary M . Human cell surface glycoprotein related to cell proliferation is the receptor for transferrin. Proc Natl Acad Sci U S A. 1981; 78(5):3039-43. PMC: 319495. DOI: 10.1073/pnas.78.5.3039. View

Sutherland R, Delia D, Schneider C, Newman R, Kemshead J, Greaves M . Ubiquitous cell-surface glycoprotein on tumor cells is proliferation-associated receptor for transferrin. Proc Natl Acad Sci U S A. 1981; 78(7):4515-9. PMC: 319822. DOI: 10.1073/pnas.78.7.4515. View

Costa A, Mazzini G, Del Bino G, Silvestrini R . DNA content and kinetic characteristics of non-Hodgkin's lymphoma: determined by flow cytometry and autoradiography. Cytometry. 1981; 2(3):185-8. DOI: 10.1002/cyto.990020310. View

Brittinger G, Schmalhorst U, Bartels H, Fulle H, Gerhartz H, Gremmel G . Principles and present status of a prospective multicenter study on the clinical relevance of the Kiel classification. Blut. 1981; 43(3):155-66. DOI: 10.1007/BF00363886. View

Diamond L, Nathwani B, Rappaport H . Flow cytometry in the diagnosis and classification of malignant lymphoma and leukemia. Cancer. 1982; 50(6):1122-35. DOI: 10.1002/1097-0142(19820915)50:6<1122::aid-cncr2820500616>3.0.co;2-q. View

Gratzner H . Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: A new reagent for detection of DNA replication. Science. 1982; 218(4571):474-5. DOI: 10.1126/science.7123245. View

Habeshaw J, Lister T, Stansfeld A, Greaves M . Correlation of transferrin receptor expression with histological class and outcome in non-Hodgkin lymphoma. Lancet. 1983; 1(8323):498-501. DOI: 10.1016/s0140-6736(83)92191-8. View

10.

Arnold A, Cossman J, Bakhshi A, Jaffe E, Waldmann T, Korsmeyer S . Immunoglobulin-gene rearrangements as unique clonal markers in human lymphoid neoplasms. N Engl J Med. 1983; 309(26):1593-9. DOI: 10.1056/NEJM198312293092601. View

11.

Christensson B, Lindemalm C, Mellstedt H, Tribukait B, Biberfeld G, Biberfeld P . Characterization of malignant and non-neoplastic cell phenotypes in highly malignant non-Hodgkin lymphomas. Int J Cancer. 1983; 32(6):667-74. DOI: 10.1002/ijc.2910320604. View

12.

Cordell J, Falini B, Erber W, Ghosh A, Abdulaziz Z, MacDonald S . Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem. 1984; 32(2):219-29. DOI: 10.1177/32.2.6198355. View

13.

Shackney S, Levine A, Fisher R, Nichols P, Jaffe E, SCHUETTE W . The biology of tumor growth in the non-Hodgkin's lymphomas. A dual parameter flow cytometry study of 220 cases. J Clin Invest. 1984; 73(4):1201-14. PMC: 425134. DOI: 10.1172/JCI111306. View

14.

Gerdes J, Lemke H, Baisch H, Wacker H, Schwab U, STEIN H . Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol. 1984; 133(4):1710-5. View

15.

Gerdes J, DALLENBACH F, Lennert K, Lemke H, STEIN H . Growth fractions in malignant non-Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody Ki-67. Hematol Oncol. 1984; 2(4):365-71. DOI: 10.1002/hon.2900020406. View

16.

Srigley J, Barlogie B, Butler J, Osborne B, Blick M, Johnston D . Heterogeneity of non-Hodgkin's lymphoma probed by nucleic acid cytometry. Blood. 1985; 65(5):1090-6. View

17.

Kvaloy S, Marton P, Kaalhus O, Hoie J, Godal T . 3H-thymidine uptake in B cell lymphomas--relationship to treatment response and survival. Scand J Haematol. 1985; 34(5):429-35. DOI: 10.1111/j.1600-0609.1985.tb00773.x. View

18.

Camplejohn R, Macartney J . Comparison of DNA flow cytometry from fresh and paraffin embedded samples of non-Hodgkin's lymphoma. J Clin Pathol. 1985; 38(10):1096-9. PMC: 499448. DOI: 10.1136/jcp.38.10.1096. View

19.

Roos G, Dige U, Lenner P, Lindh J, Johansson H . Prognostic significance of DNA-analysis by flow cytometry in non-Hodgkin's lymphoma. Hematol Oncol. 1985; 3(4):233-42. DOI: 10.1002/hon.2900030403. View

20.

Wright D . T-cell lymphomas. Histopathology. 1986; 10(3):321-6. DOI: 10.1111/j.1365-2559.1986.tb02486.x. View